OCTP.L
Oxford Cannabinoid Technologies Holdings Plc [OCTP.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
OCTP.L Stock Summary
Top 10 Correlated ETFs
OCTP.L
Top 10 Correlated Stocks
OCTP.L
In the News
OCTP.L Financial details
Company Rating
Neutral
Market Cap
3.97M
Income
-7.95M
Revenue
0
Book val./share
0
Cash/share
0
Dividend
-
Dividend %
-
Employees
7
Optionable
No
Shortable
Yes
Earnings
03 Jul 2024
P/E
-1.67
Forward P/E
-
PEG
-0.23
P/S
-
P/B
-
P/C
-
P/FCF
-1437.03
Quick Ratio
3.93
Current Ratio
7.69
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.01
EPS next Y
-
EPS next Q
-
EPS this Y
14.81%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-8.7%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.313-1.6
52W High
-
52W Low
-
RSI
29
Rel Volume
2.75
Avg Volume
4.75M
Volume
13.05M
Perf Week
-1.47%
Perf Month
-22.09%
Perf Quarter
-53.79%
Perf Half Y
-56.77%
-
-
-
-
Beta
0.79
-
-
Volatility
0.01%, 0.04%
Prev Close
-4.29%
Price
0.335
Change
-6.29%
OCTP.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-04-30
| Metric | History | 2019-05-31 | 2020-05-31 | 2021-05-31 | 2022-04-30 | 2023-04-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | -0.01 | -0.01 | |
| Operating cash flow per share | 0 | 0 | 0 | -0.01 | -0.01 | |
| Free cash flow per share | 0 | 0 | 0 | -0.01 | -0.01 | |
| Cash per share | 0 | 0 | 0.02 | 0.01 | 0 | |
| Book value per share | 0 | 0 | 0.01 | 0.01 | 0 | |
| Tangible book value per share | 0 | 0 | 0.01 | 0.01 | 0 | |
| Share holders equity per share | 0 | 0 | 0.01 | 0.01 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 48.02M | 48.02M | 39.38M | 11.28M | 12.73M | |
| Enterprise value | 46.37M | 47.82M | 24.92M | 2.12M | 10.43M | |
| P/E ratio | -18.35 | -22.44 | -12.2 | -2.2 | -2.14 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -16.25 | -26.86 | -22.14 | -2.1 | -1.85 | |
| PFCF ratio | -15.85 | -23 | -22.13 | -2.1 | -1.85 | |
| P/B Ratio | 26.86 | 89.96 | 2.77 | 1.15 | 3.25 | |
| PTB ratio | 26.86 | 89.96 | 2.77 | 1.15 | 3.25 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -36.17 | -37.97 | -8.98 | -0.36 | -1.49 | |
| EV to operating cash flow | -15.69 | -26.75 | -14.01 | -0.39 | -1.52 | |
| EV to free cash flow | -15.3 | -22.9 | -14 | -0.39 | -1.52 | |
| Earnings yield | -0.05 | -0.04 | -0.08 | -0.46 | -0.47 | |
| Free cash flow yield | -0.06 | -0.04 | -0.05 | -0.48 | -0.54 | |
| Debt to equity | 0 | 0.2 | 0.01 | 0 | 0 | |
| Debt to assets | 0 | 0.08 | 0.01 | 0 | 0 | |
| Net debt to EBITDA | 1.28 | 0.16 | 5.21 | 1.54 | 0.33 | |
| Current ratio | 4.14 | 1.41 | 15.83 | 5.81 | 7.69 | |
| Interest coverage | -139.77 | -114.48 | -49.41 | 0 | 0 | |
| Income quality | 1.13 | 0.84 | 0.55 | 1.05 | 1.16 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.06 | 0.11 | 0.01 | 0 | 0 | |
| Capex to operating cash flow | 0.03 | 0.17 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -44.27 | -3.62 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.01 | 0.01 | 0.03 | 0.04 | 0.02 | |
| ROIC | -1.41 | -2.83 | -0.22 | -0.52 | -1.52 | |
| Return on tangible assets | -1.19 | -1.82 | -0.21 | -0.44 | -1.32 | |
| Graham Net | 0 | 0 | 0.01 | 0.01 | 0 | |
| Working capital | 1.71M | 295.97K | 14.1M | 9.75M | 3.9M | |
| Tangible asset value | 1.65M | 393.11K | 14.11M | 9.75M | 3.9M | |
| Net current asset value | 1.71M | 243.13K | 14.05M | 9.75M | 3.9M | |
| Invested capital | 0 | 0.2 | 0.01 | 0 | 0 | |
| Average receivables | 0 | 0 | 210.95K | 1.51M | 2.4M | |
| Average payables | 295.74K | 400.7K | 495.44K | 251.09K | 1.04K | |
| Average inventory | 0 | 0 | -210.95K | -212.26K | -2.4K | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 88.52 | 143.89 | 410.06 | 10.32 | 2.69 | |
| Days of inventory on hand | 0 | 0 | -345.75 | -14.96 | -20.61 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 4.12 | 2.54 | 0.89 | 35.36 | 135.57 | |
| Inventory turnover | 0 | 0 | -1.06 | -24.39 | -17.71 | |
| ROE | -1.46 | -4.01 | -0.23 | -0.52 | -1.52 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-10-31 for Q2
| Metric | History | 2021-11-30 | 2021-11-30 | 2022-10-31 | 2023-04-30 | 2023-10-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0.01 | 0 | 0 | |
| Book value per share | 0 | 0 | 0.01 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0.01 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0.01 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 22.81K | 5.52M | 12.73M | 6.96M | |
| Enterprise value | -11.96M | 0 | 589.56K | 10.43M | 5.83M | |
| P/E ratio | 0 | -5.62 | -0.37 | -1.42 | -0.87 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | -1.3K | -4.83K | -5.99K | |
| PFCF ratio | 0 | 0 | -1.3K | -4.83K | -5.99K | |
| P/B Ratio | 0 | 0 | 0.9 | 3.25 | 3.57 | |
| PTB ratio | 0 | 0 | 0.9 | 3.25 | 3.57 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 0 | -132.22 | -4.11K | -2.43 | |
| EV to operating cash flow | 4.63K | 0 | -139.28 | -3.96K | -5.01K | |
| EV to free cash flow | 4.63K | 0 | -139.28 | -3.96K | -5.01K | |
| Earnings yield | 0 | -0.04 | -0.67 | -0.18 | -0.29 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0 | 0 | 1.11K | 904.59 | 0.47 | |
| Current ratio | 22.41 | 0 | 5.79 | 7.69 | 3.32 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 1.27 | 0 | 1.14 | 1.18 | 0.58 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0.02 | 0.01 | 0.01 | |
| ROIC | 0 | 0 | -0.6 | -0.57 | -1.03 | |
| Return on tangible assets | 0 | 0 | -0.5 | -0.5 | -0.72 | |
| Graham Net | 0 | 0 | 0.01 | 0 | 0 | |
| Working capital | 12.28M | 0 | 6.12M | 3.9M | 1.95M | |
| Tangible asset value | 12.3M | 0 | 6.12M | 3.9M | 1.95M | |
| Net current asset value | 12.28M | 0 | 6.12M | 3.9M | 1.95M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 259.33K | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 36.58 | 22.28 | 64.51 | |
| Days of inventory on hand | 0 | 0 | -70.55 | -170.57 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 2.46 | 4.04 | 1.4 | |
| Inventory turnover | 0 | 0 | -1.28 | -0.53 | 0 | |
| ROE | 0 | 0 | -0.6 | -0.57 | -1.03 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
OCTP.L Frequently Asked Questions
What is Oxford Cannabinoid Technologies Holdings Plc stock symbol ?
Oxford Cannabinoid Technologies Holdings Plc is a GB stock and trading under the symbol OCTP.L
What is Oxford Cannabinoid Technologies Holdings Plc stock quote today ?
Oxford Cannabinoid Technologies Holdings Plc stock price is $0.335 today.
Is Oxford Cannabinoid Technologies Holdings Plc stock public?
Yes, Oxford Cannabinoid Technologies Holdings Plc is a publicly traded company.
Company Profile
- Volume Average 4.75M
- Market Capitalization 3.97M
- Employee 7
- CEO Ms. Clarissa Ann Sowemimo-Coker
- Headquarters London,GB
- IPO Date 2021-05-21
-
Website
https://www.oxcantech.com 
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate is OCT461201, a selective CB2 receptor agonist in solid oral dosage form that is in pre-clinical development for use in the treatment of IBS-associated visceral pain, as well as neuropathic pain conditions, including post herpetic neuralgia. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.
